Lamotrigine Tablet, Film Coated, Extended Release
Product Images NDC 82804-022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 82804-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

100 mg Tab (100mg Picture)

100 mg Tab (100mg Picture)
FDA Label Image

200 mg Tab (200mg Picture)

200 mg Tab (200mg Picture)
FDA Label Image

250 mg Tab (250mg Picture)

250 mg Tab (250mg Picture)
FDA Label Image

25 mg Tab (25mg Picture)

25 mg Tab (25mg Picture)
FDA Label Image

300 mg Tab (300mg Picture)

300 mg Tab (300mg Picture)
FDA Label Image

50 mg Tab (50mg Picture)

50 mg Tab (50mg Picture)
FDA Label Image

Figure 1. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (primary Generalized Tonic-clonic Seizures Study) (Figure 1)

Figure 1. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (primary Generalized Tonic-clonic Seizures Study) (Figure 1)
FDA Label Image

Figure 2. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (partial-onset Seizure Study) (Figure 2)

Figure 2. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (partial-onset Seizure Study) (Figure 2)
FDA Label Image

Chemical Structure (Graphic 01)

Chemical Structure (Graphic 01)
FDA Label Image

82804-022-30 (Label 50mg 30tablets)

82804-022-30 (Label 50mg 30tablets)